Protagenic Therapeutics, Inc. PTIX
PTIX
Protagenic Therapeutics, Inc. SLRX
Salarius Pharmaceuticals, Inc. LIPO
Lipella Pharmaceuticals Inc. ARTL
Artelo Biosciences, Inc. INDP
Indaptus Therapeutics, Inc. SLXN
Silexion Therapeutics Ltd. REVB
Revelation Biosciences, Inc. CARM
Carisma Therapeutics, Inc. SPRC
SciSparc Ltd. GTBP
GT Biopharma, Inc.
Protagenic Therapeutics, Inc. SLRX
Salarius Pharmaceuticals, Inc. LIPO
Lipella Pharmaceuticals Inc. ARTL
Artelo Biosciences, Inc. INDP
Indaptus Therapeutics, Inc. SLXN
Silexion Therapeutics Ltd. REVB
Revelation Biosciences, Inc. CARM
Carisma Therapeutics, Inc. SPRC
SciSparc Ltd. GTBP
GT Biopharma, Inc.
Performance
| Periode | PTIX | SLRX | LIPO | ARTL | INDP | SLXN | REVB | CARM | SPRC | GTBP |
|---|---|---|---|---|---|---|---|---|---|---|
| 6M | -66.57 % | -96.03 % | -86.97 % | -72.79 % | -73.15 % | -80.38 % | -60.14 % | -89.12 % | -76.53 % | -75.18 % |
| YTD | -83.63 % | -97.38 % | -93.24 % | -75.99 % | -91.52 % | -91.96 % | -97.17 % | -89.09 % | -82.28 % | -74.26 % |
| 1Y | -84.09 % | -97.09 % | -93.06 % | -72.74 % | -91.84 % | -93.68 % | -93.85 % | -87.63 % | -70.14 % | -73.06 % |
| 3Y | -95.25 % | -99.52 % | -99.40 % | -91.28 % | -95.35 % | -99.09 % | -99.99 % | -99.52 % | -99.65 % | -97.75 % |
| 5Y | -99.06 % | -99.97 % | -96.26 % | -97.20 % | -99.55 % | -99.09 % | -100.00 % | -99.81 % | -99.94 % | -99.70 % |
| 10Y | -99.06 % | -100.00 % | -96.26 % | -99.62 % | -99.98 % | -99.09 % | -100.00 % | -99.92 % | -99.94 % | -100.00 % |
| Depuis le début | -99.06 % | -100.00 % | -96.26 % | -99.62 % | -99.98 % | -99.09 % | -100.00 % | -99.98 % | -99.94 % | -100.00 % |